Safety Results from the Phase 3 MajesTEC-7 Study in Patients (pts) with Transplant Ineligible/not Intended Newly Diagnosed Multiple Myeloma (NDMM).
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2024)